药物遗传学对心力衰竭患者的结局的影响
Neven Sarhan1, Mona F Schaalan1, Azza A K El-Sheikh2
1Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo 11314, Egypt.
Pharmaceutics
|August 28, 2025
概括
在接受达帕格利弗洛辛治疗的心力衰竭患者中,SLC5A2和UMOD的遗传变异会影响功能. 这种药物遗传学的洞察力可以个性化治疗以改善的结果.
科学领域:
- 药物基因组学
- 心脏病医学
- 心脏衰竭的遗传学
背景情况:
- 心脏衰竭与减少的喷射分数 (HFrEF) 经常涉及脏并发症,预后恶化.
- 像达帕格利弗洛辛这样的-葡萄糖辅运输体-2 (SGLT2) 抑制剂在HFrEF中具有心脏和脏的益处.
- 个人对达帕格利弗洛辛的反应有所不同,这表明药物遗传学起了作用.
研究的目的:
- 在接受达帕格利弗洛辛的HFrEF患者中,研究遗传多态如何影响结局.
- 分析包括SLC5A2,UMOD,KCNJ11和ACE在内的基因变异.
- 在HFrEF中确定优化达帕格利弗洛辛治疗的遗传标记.
主要方法:
- 在埃及开罗对200名HFrEF患者进行前性观察队列研究.
- 使用TaqManTM试验对单核酸多态 (SNP) 的基因定型.
- 评估基线和6个月的估计球过率 (eGFR),KIM-1和NGAL水平.
主要成果:
- 特定的SLC5A2 (rs3813008AA基因型) 和UMOD (rs12917707TT基因型) 变异与改善的功能有关.
- 患有rs3813008AA基因型的患者表现出显著的eGFR增加和KIM-1和NGAL的减少.
- 没有发现KCNJ11 (rs5219) 多态性对结局有显著影响.
结论:
- 药物遗传变异,特别是在SLC5A2和UMOD中,显著影响达帕格利弗洛辛在HFrEF中的效应.
- 这些发现支持个性化药物的潜力,以定制HFrEF治疗.
- 基因分析可以优化达帕格利弗洛辛治疗,以改善HFrEF患者的结局.
相关概念视频
Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
226
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
226


